SCHOTT Pharma AG & Co. KGaA (STTPF)
SCHOTT Pharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2025 | 0.00 |
| September 30, 2024 | 0.1086 |
| June 30, 2024 | 0.1221 |
| March 31, 2024 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.1048 |
| December 31, 2022 | |
| September 30, 2022 | 0.1058 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Evotec SE | 0.715 |
| Sartorius AG | 1.436 |
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |